Concurrent Investment Advisors LLC purchased a new stake in Constellium SE (NYSE:CSTM - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 97,785 shares of the industrial products company's stock, valued at approximately $3,116,000. Concurrent Investment Advisors LLC owned about 0.07% of Constellium as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CSTM. Royal Bank of Canada boosted its stake in shares of Constellium by 5.3% in the first quarter. Royal Bank of Canada now owns 72,526 shares of the industrial products company's stock worth $732,000 after buying an additional 3,629 shares during the last quarter. AQR Capital Management LLC raised its position in Constellium by 354.0% during the first quarter. AQR Capital Management LLC now owns 91,566 shares of the industrial products company's stock valued at $924,000 after acquiring an additional 71,396 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Constellium by 4.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 77,021 shares of the industrial products company's stock valued at $777,000 after acquiring an additional 3,393 shares in the last quarter. Prudential Financial Inc. acquired a new position in Constellium in the second quarter valued at approximately $218,000. Finally, Norges Bank acquired a new position in Constellium in the second quarter valued at approximately $1,499,000. 92.59% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several research firms have commented on CSTM. Deutsche Bank Aktiengesellschaft set a $39.00 price objective on Constellium in a research report on Thursday, July 30th. Wells Fargo & Company lifted their target price on shares of Constellium from $37.00 to $39.00 and gave the company an "overweight" rating in a report on Thursday, July 30th. Zacks Research cut shares of Constellium from a "strong-buy" rating to a "hold" rating in a research note on Monday, June 29th. UBS Group lowered their price target on shares of Constellium from $38.00 to $35.00 and set a "buy" rating on the stock in a report on Wednesday, July 8th. Finally, Weiss Ratings lowered shares of Constellium from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Wednesday, July 1st. Four research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $35.80.
Read Our Latest Stock Report on CSTM
Insider Activity
In other Constellium news, Director Jean-Christophe Deslarzes bought 1,490 shares of the company's stock in a transaction dated Monday, August 3rd. The stock was acquired at an average price of $27.24 per share, with a total value of $40,587.60. Following the completion of the acquisition, the director directly owned 43,515 shares of the company's stock, valued at $1,185,348.60. This represents a 3.55% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.20% of the stock is owned by insiders.
Constellium Stock Performance
Shares of NYSE:CSTM opened at $27.17 on Tuesday. The company has a debt-to-equity ratio of 1.50, a current ratio of 1.43 and a quick ratio of 0.61. The business's 50 day moving average price is $28.56 and its 200-day moving average price is $29.43. The firm has a market capitalization of $3.68 billion, a PE ratio of 7.00 and a beta of 1.55. Constellium SE has a 1 year low of $13.60 and a 1 year high of $36.99.
Constellium (NYSE:CSTM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The industrial products company reported $1.04 EPS for the quarter, beating the consensus estimate of $0.86 by $0.18. The firm had revenue of $2.75 billion during the quarter, compared to the consensus estimate of $2.73 billion. Constellium had a return on equity of 51.66% and a net margin of 5.69%.The firm's revenue was up 30.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.25 EPS. As a group, equities research analysts expect that Constellium SE will post 3.7 earnings per share for the current fiscal year.
About Constellium
(
Free Report)
Constellium SE is a global leader in the design and manufacture of high-performance aluminum products and solutions. The company serves key markets including aerospace, automotive, and packaging, offering advanced rolled and extruded aluminum sheet, plate and structural components. Its product portfolio encompasses precision-engineered parts for commercial and military aircraft, automotive body structures and closures, beverage and specialty packaging, as well as industrial and structural applications.
Established in 2011 through the consolidation of Rio Tinto Alcan's rolled-products and engineered-products businesses, Constellium has built a reputation for innovation in lightweighting and sustainability.
Further Reading
Want to see what other hedge funds are holding CSTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Constellium SE (NYSE:CSTM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Constellium, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Constellium wasn't on the list.
While Constellium currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.